to acquire British investment firm Actis Capital in January 2024. The acquisition finalized in October, after which Actis became General Atlantic's sustainable infrastructure arm.

Investments

General Atlantic backed Royalty Pharma ahead of the company's 2020 IPO, which was among the largest U.S. IPOs that year and was the second-largest pharmaceutical listing ever. The firm also expanded its footprint in Asia in 2020 with an $870 million investment

1.Previous
3.Next